岩藻糖基化
细胞培养中氨基酸的稳定同位素标记
糖基化
岩藻糖基转移酶
化学
基因敲除
岩藻糖
衣霉素
聚糖
生物化学
N-连接糖基化
蛋白质组学
内质网
未折叠蛋白反应
糖蛋白
酶
基因
作者
Rubén López-Cortés,Laura Muinelo‐Romay,Almudena Fernández‐Briera,Emilio Gil‐Martín
标识
DOI:10.1021/acs.jproteome.3c00833
摘要
High Resolution Image Download MS PowerPoint Slide Disruption of the glycosylation machinery is a common feature in many types of cancer, and colorectal cancer (CRC) is no exception. Core fucosylation is mediated by the enzyme fucosyltransferase 8 (FucT-8), which catalyzes the addition of α1,6- l -fucose to the innermost GlcNAc residue of N -glycans. We and others have documented the involvement of FucT-8 and core-fucosylated proteins in CRC progression, in which we addressed core fucosylation in the syngeneic CRC model formed by SW480 and SW620 tumor cell lines from the perspective of alterations in their N -glycosylation profile and protein expression as an effect of the knockdown of the FUT8 gene that encodes FucT-8. Using label-free, semiquantitative mass spectrometry (MS) analysis, we found noticeable differences in N -glycosylation patterns in FUT8 -knockdown cells, affecting core fucosylation and sialylation, the Hex/HexNAc ratio, and antennarity. Furthermore, stable isotopic labeling of amino acids in cell culture (SILAC)-based proteomic screening detected the alteration of species involved in protein folding, endoplasmic reticulum (ER) and Golgi post-translational stabilization, epithelial polarity, and cellular response to damage and therapy. This data is available via ProteomeXchange with identifier PXD050012. Overall, the results obtained merit further investigation to validate their feasibility as biomarkers of progression and malignization in CRC, as well as their potential usefulness in clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI